PBMI: Real-world Impact of Pharmacogenomics
Jeffrey A. Shaman, Ph.D., chief science officer at Coriell Life Sciences, talked about how pharmacogenomics can inform medication management.
PBMI: Drug Benefit Design for Specialty Medications
Kali Panagos, Pharm.D., at ARMSRx, discusses the growing trend of copay assistance programs and alternative funding solutions that can help provide access to expensive specialty therapies.
2 Clarke Drive Cranbury, NJ 08512